Laboratory monitoring Your provider should order baseline labs before starting the combination and repeat them at 4-8 week intervals
While the outcomes of such early test trials are not binding on other claims, they are often critical to help the parties gauge how juries are likely to respond to certain evidence and testimony that will be repeated throughout the litigation, potentially facilitating Ozempic settlement negotiations that would avoid the need for each individual case to be set for trial in the future
Interestingly, GI adverse events and GLP-1 RA discontinuations were more common in participants not treated with metformin, which may represent increased susceptibility of this group to gut-related adverse events, resulting in intolerance to metformin previously as well as to GLP-1 RAs in the trials
And thats the short list
Continue monitoring During GLP-1 receptor agonist therapy, monitor patients for the following signs or symptoms of acute pancreatitis: Weight loss of more than 1.5 kg per week is usually associated with prolonged periods of fasting or anorexia and, as discussed earlier, causes the release of cholesterol into the bile and induces bile stasis